XIAP and liver cancer: Our findings reveal that circKIF5B can regulate XIAP expression by sponging miR-192 and miR-215 competing for the ceRNA mechanism, indicating that circKIF5B acts as a critical upstream regulator and supporting the notion that circKIF5B/miR-192s/XIAP is a promising therapeutic target for liver cancer.